SCHEMBL1067002

SCHEMBL1067002

O=[N+]([O-])c1ccc(-n2ccnc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 4/20 0.55
LMNA P02545 1/20 0.55
MAPT P10636 1/20 0.55
ENPP2 Q13822 1/20 0.55
MKNK1 Q9BUB5 1/20 0.55
MKNK2 Q9HBH9 1/20 0.55
NOTUM Q6P988 1/20 0.55
CYP3A4 P08684 2/20 0.53
KMT2A Q03164 2/20 0.53
MEN1 O00255 1/20 0.51
ALOX15 P16050 1/20 0.51
TSHR P16473 1/20 0.51
BAZ2B Q9UIF8 1/20 0.51
ADH5 P11766 1/20 0.49
HTT P42858 1/20 0.47
HTR2A P28223 1/20 0.46
HTR2C P28335 1/20 0.46
HTR2B P41595 1/20 0.46
CYP51A1 Q16850 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5836351 0.91 CYP19A1 (0.48) CYP19A1LMNAMAPTENPP2MKNK1
SCHEMBL27910907 0.91 CYP51A1 (0.50) CYP19A1LMNAMAPTENPP2MKNK1
SCHEMBL328169 0.91 HSPB1 (0.49) CYP19A1LMNAMAPTENPP2MKNK1
SCHEMBL6324609 0.89 L3MBTL1 (0.60) CYP19A1LMNAMAPTENPP2MKNK1
SCHEMBL10756652 0.88 CYP19A1 (0.56) CYP19A1LMNAMAPTENPP2MKNK1
SCHEMBL2532397 0.80 LMNA (0.78) CYP19A1LMNAMAPTENPP2MKNK1
SCHEMBL2627217 0.80 IDO1 (0.59) CYP19A1LMNAMAPTCYP3A4KMT2A
SCHEMBL27807398 0.78 GRIA1 (0.49) CYP19A1LMNAMAPTENPP2MKNK1
SCHEMBL19036206 0.78 GRIK1 (0.49) CYP19A1MAPTKMT2A
Hydrochloric Acid SCHEMBL28701756 0.78 LMNA (0.75) CYP19A1LMNAMAPTENPP2MKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112581856-B Temperature indicating label 苏州和萃新材料有限公司 2022-07-19 CN claimed
CN-113789086-A High-temperature color-changing ink and label 江苏集萃智能液晶科技有限公司 2021-12-14 CN claimed
CN-109065832-B Method for growing protective layer on surface of metal negative electrode of secondary lithium battery 武汉船用电力推进装置研究所(中国船舶重工集团公司第七一二研究所) 2021-07-09 CN claimed
CN-112581856-A Temperature indicating label 苏州和萃新材料有限公司 2021-03-30 CN claimed
CN-111730243-A Water-soluble flux composition for hot air leveling 东莞市硕美电子材料科技有限公司 2020-10-02 CN claimed
CN-105705656-B Method of producing a composite material 牛津纳米孔技术公司 2020-02-21 CN claimed
CN-110343205-A Side group functionalized polyisobutylene base thermoplastic elastomer and preparation method thereof 北京化工大学 2019-10-18 CN claimed
CN-108062998-B Conductive nano carbon paste composition and preparation method thereof 深圳市源恒来实业有限公司 2019-07-16 CN claimed
CN-109336756-A A kind of hydrogenation-dehalogenation method of halogenated aromatic 河南大学 2019-02-15 CN claimed
CN-109065832-A A method of in serondary lithium battery metal negative electrode surface growth protecting layer 武汉船用电力推进装置研究所(中国船舶重工集团公司第七二研究所) 2018-12-21 CN claimed
US-20080214856-A1 Process for preparation of dialkyl carbonate CHINA PETROCHEMICAL DEVELOPMENT CORPORATION (TW) 2008-09-04 US claimed
EP-1947080-A2 Process for preparation of dialkyl carbonate China Petrochemical Development Corporation (TW) 2008-07-23 EP claimed
US-20080051552-A1 Polymers functionalized with nitro compounds BRIDGESTONE CORPORATION 2008-02-28 US claimed
US-20080051519-A1 Polymers functionalized with nitro compounds BRIDGESTONE CORPORATION (JP) 2008-02-28 US claimed
EP-0365907-B1 Process for the preparation of p-nitrophenyl imidazoles BASF AG (DE) 1993-12-22 EP claimed
US-5008398-A Preparation of p-nitrophenyl-imidazoles BASF AKTIENGESELLSCHAFT (DE) 1991-04-16 US claimed
EP-0365907-A1 Process for the preparation of p-nitrophenyl imidazoles BASF Aktiengesellschaft (DE) 1990-05-02 EP claimed
EP-0028410-B1 USE OF THROMBOXANE-SYNTHETASE INHIBITING COMPOUNDS IN THE TREATMENT OF OBESITY AND THE LOWERING OF INSULIN LEVELS F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1987-09-30 EP claimed
US-4500540-A DIETETICS HOFFMANN-LA ROCHE INC. (US) 1985-02-19 US claimed
EP-0028410-A1 Use of thromboxane-synthetase inhibiting compounds in the treatment of obesity and the lowering of insulin levels F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1981-05-13 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214856-A1 Process for preparation of dialkyl carbonate ADH5, ADH1C, CBR3 CYP19A1 1383/4885LMNA 2964/4885MAPT 3685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.